Skip to content
DataLookout
Menu

NCT07250724

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 12 words Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Primary completion pushed from Oct 15, 2026 to Jan 15, 2027
    • Study completion pushed from Oct 15, 2026 to Jan 31, 2027
    • Site details revised at 4 of 4 sites
  2. Notable Eligibility criteria expanded, about 32 words
    • Trial sites expanded: 1 → 4 locations
    v5
  3. Minor Start date changed from estimate of Feb 1, 2026 to Mar 1, 2026v4
  4. Notable Start date: Dec 1, 2025 to Feb 1, 2026
    • Site contact updated
    v3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

The proportion of subjects experiencing CDI recurrence in the time period between baseline and end of study follow-up.
Timeframe: Within the 8 week time period between baseline and end of follow-up

Arms and interventions

Other: Participants that are undergoing standard of care antibiotic treatment for their second C. Diff infection will be followed for 8 weeks after completing antibiotic treatment.

Sites

4 sites in 1 country